✦ LIBER ✦
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer models and acts by CR2-dependent targeting of CR1 regulatory activity
✍ Scribed by Michael Holers; Nirmal Banda; Gaurav Mehta; Masha Fridkis-Hareli; Eran Or; Michael Storek; Richard Altman; Krista Johnson; Suresh Katti
- Book ID
- 118459509
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 69 KB
- Volume
- 217
- Category
- Article
- ISSN
- 0171-2985
No coin nor oath required. For personal study only.